研發體系手機端標題
Adhering to the development path of industry university research, relying on the technical advantages of famous scientific research institutes such as the Chinese Academy of traditional Chinese medicine, Beijing University of traditional Chinese medicine and the Central Research Institute of the group, the company continued to carry out the development of new varieties of traditional Chinese medicine and the secondary development of famous and high-quality Chinese patent medicines, realized the organic combination of independent research and development and cooperative research, and formed Xinhuang Tablets, babaodan, Shenshu granules A group of compound Chinese patent medicines represented by Qigu capsule have independent intellectual property rights and major market prospects at home and abroad.
In recent years, the company has undertaken a number of major national, provincial and municipal projects, and has obtained 10 invention patents and 14 utility model patents. Among them, "Research on babaodan capsule and related technology" (2019zx9201005-002-005) was listed as a major national science and technology project in 2019; "Clinical reevaluation study of osteoporosis drug Qigu capsule after listing" was selected as the subject of Shanghai scientific research plan.
cc1
